Sedoselecta en es it fr

Sedoselecta Brand names, Sedoselecta Analogs

Sedoselecta Brand Names Mixture

  • No information avaliable

Sedoselecta Chemical_Formula


Sedoselecta RX_link

No information avaliable

Sedoselecta fda sheet

Sedoselecta msds (material safety sheet)

Sedoselecta Synthesis Reference

No information avaliable

Sedoselecta Molecular Weight

309.469 g/mol

Sedoselecta Melting Point

< 25 oC

Sedoselecta H2O Solubility

Soluble as HCl salt

Sedoselecta State


Sedoselecta LogP


Sedoselecta Dosage Forms

Tablets (oral, 1 mg)

Sedoselecta Indication

Used for the symptomatic treatment of parkinsonism.

Sedoselecta Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Sedoselecta Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Sedoselecta side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Sedoselecta Patient Information

Sedoselecta Organisms Affected

Humans and other mammals